GILEAD SCIENCES LDA. secures contract for Acquisition Of Sofosb Velpat Voxilap 400 100 100Mg Cp, To Lab Gilead, For Ulsasi, For The Year 2025

Portugal, April 7 -- Portugal based GILEAD SCIENCES LDA. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Sofosb Velpat Voxilap 400 100 100Mg Cp, To Lab Gilead, For Ulsasi, For The Year 2025. The value of the contract is worth 1167300 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....